Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana; Center for Health Innovation and Implementation Science, Indianapolis, Indiana.
Nursing Research Division, Department of Nursing, Mayo Clinic, Rochester, Minnesota.
J Surg Res. 2024 Jun;298:222-229. doi: 10.1016/j.jss.2024.03.018. Epub 2024 Apr 15.
Anticholinergic medications are known to cause adverse cognitive effects in community-dwelling older adults and medical inpatients, including dementia. The prevalence with which such medications are prescribed in older adults undergoing major surgery is not well described nor is their mediating relationship with delirium and dementia. We sought to determine the prevalence of high-risk medication use in major surgery patients and their relationship with the subsequent development of dementia.
This was a retrospective cohort study which used data between January 2013 and December 2019, in a large midwestern health system, including sixteen hospitals. All patients over age 50 undergoing surgery requiring an inpatient stay were included. The primary exposure was the number of doses of anticholinergic medications delivered during the hospital stay. The primary outcome was a new diagnosis of Alzheimer's disease and related dementias at 1-y postsurgery. Regression methods and a mediation analysis were used to explore relationships between anticholinergic medication usage, delirium, and dementia.
There were 39,665 patients included, with a median age of 66. Most patients were exposed to anticholinergic medications (35,957/39,665; 91%), and 7588/39,665 (19.1%) patients received six or more doses during their hospital stay. Patients with at least six doses of these medications were more likely to be female, black, and with a lower American Society of Anesthesiologists class. Upon adjusted analysis, high doses of anticholinergic medications were associated with increased odds of dementia at 1 y relative to those with no exposure (odds ratio 2.7; 95% confidence interval 2.2-3.3). On mediation analysis, postoperative delirium mediated the effect of anticholinergic medications on dementia, explaining an estimated 57.6% of their association.
High doses of anticholinergic medications are common in major surgery patients and, in part via a mediating relationship with postoperative delirium, are associated with the development of dementia 1 y following surgery. Strategies to decrease the use of these medications and encourage the use of alternatives may improve long-term cognitive recovery.
已知抗胆碱能药物会对社区居住的老年患者和住院患者造成认知不良影响,包括痴呆症。在接受大手术的老年患者中,此类药物的开处方频率尚不清楚,其与谵妄和痴呆的关系也尚未阐明。我们旨在确定大手术患者中高危药物的使用频率及其与随后痴呆症发展的关系。
这是一项回顾性队列研究,使用了 2013 年 1 月至 2019 年 12 月期间,在一个中西部大型卫生系统中 16 家医院的数据。纳入所有 50 岁以上接受需要住院治疗的手术的患者。主要暴露因素为住院期间给予的抗胆碱能药物剂量数。主要结局是手术后 1 年新诊断为阿尔茨海默病和相关痴呆症。回归方法和中介分析用于探索抗胆碱能药物使用、谵妄和痴呆之间的关系。
共纳入 39665 例患者,中位年龄为 66 岁。大多数患者使用了抗胆碱能药物(35957/39665;91%),39665 例患者中有 7588/39665(19.1%)例患者在住院期间接受了 6 剂或以上药物。接受这些药物 6 剂以上的患者更可能为女性、黑人,且美国麻醉医师协会(American Society of Anesthesiologists)分级较低。经调整分析,与无暴露组相比,高剂量抗胆碱能药物与术后 1 年痴呆症的发生风险增加相关(比值比 2.7;95%置信区间 2.2-3.3)。在中介分析中,术后谵妄部分解释了抗胆碱能药物对痴呆症的影响,占其相关性的估计 57.6%。
大手术患者中抗胆碱能药物的使用频率较高,部分通过与术后谵妄的中介关系,与术后 1 年发生痴呆症有关。减少这些药物的使用并鼓励使用替代药物的策略可能会改善长期认知恢复。